Depression - Major Depressive Disorder
164
63
74
24
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 164 trials
100.0%
+13.5% vs benchmark
5%
9 trials in Phase 3/4
4%
1 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (164)
Analgesic Efficacy of Multisite rTMS in Fibromyalgia Patients
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Mobile Cognitive Behavioral Therapy in Early Stroke Recovery
Enhancing Slow Wave Sleep in Depression
HIV-Mental Illness Stigma Reduction and Outcomes in Malawi
Mindfulness-based Psilocybin Therapy for PTSD
Stronger Together: Antenatal Depressive Symptoms - Prevalence and Digital Treatment
Effects of Concurrent and Consecutive Repetitive Transcranial Magnetic Stimulation (rTMS) and Cognitive Bias Modification (CBM)
Comparing Outcomes of Theta Burst Stimulation in Depression Using Advanced PET Imaging
EEG Prediction and Clinical Efficacy of tDCS in Major Depression
iPath for CP Pilot
Youth Suicide Prevention: CAMS-BI vs. Safety Planning in a Randomized Trial
Lumateperone for Late-Life Depression
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
Intervention to Reduce HIV Related Stigma Among Pregnant and Postpartum Women
Mindful Self-Compassion to Address PTSD and Substance Use in Unhoused Women
Group-based ACT for Psychological Distress of Young People
Flumazenil for Benzodiazepine Reversal in Electroconvulsive Therapy
Stress Management and Meditative Movements for Asian Americans With Depression and Physical Symptoms
Feasibility, Safety, and Preliminary Clinical Efficacy of Magnetic Resonance Imaging-guided Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression: A Randomized, Double-Blind, Controlled Pilot Study